Skip to content

Member

Adam JARUBAS

EPP · Poland

Group
EPP PPE
Country
Poland
Roll-call participation
76.9 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
95.0 %ⓘ of 477 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
PSL Polskie Stronnictwo Ludowe
In office
Since 16 Jul 2024
Against clear line
14 of 452 votesⓘ
Committees
ENVI (substitute), ITRE, SANT (chair)
Member id
197517
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

76.9 %

477 of 620 final votes while in office

EPP median: 90.6 % (−13.6 pts)

Chamber median: 90.6 %

With majority line ⓘ

95.0 %

453 of 477 votes where their group had a line

EPP median: 95.6 % (−0.6 pts)

Against clear line ⓘ

3.1 %

14 of 452 votes where their group had a clear line

8 opposite (for ↔ against), 6 abstained against the line

Abstention ⓘ

2.3 %

11 of 477 votes cast

Participation 76.9 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Adam JARUBAS76.9 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 95.0 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Adam JARUBAS95.0 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
11 Mar 2026Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty Adopted 482 for, 108 against, 42 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Tackling barriers to the single market for defence Adopted 393 for, 169 against, 67 abstainedPosition: No vote recorded Majority line: For
11 Mar 2026Flagship European defence projects of common interest Adopted 448 for, 122 against, 38 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Harmonising certain aspects of insolvency law Passed 498 for, 90 against, 28 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Establishing an EU talent pool Passed 414 for, 182 against, 21 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Increased efficiency of the External Action Guarantee Passed 441 for, 105 against, 81 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024 Adopted 493 for, 92 against, 44 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing Adopted 367 for, 166 against, 84 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Public access to documents - report 2022 - 2024 Adopted 602 for, 9 against, 8 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Copyright and generative artificial intelligence – opportunities and challenges Adopted 460 for, 71 against, 88 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefiting local economies Adopted 528 for, 21 against, 62 abstainedPosition: No vote recorded Majority line: For
10 Mar 2026The upcoming European Research Area (ERA) Act Adopted 399 for, 78 against, 69 abstainedPosition: No vote recorded Majority line: For
24 Feb 2026Four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine Adopted 437 for, 82 against, 70 abstainedPosition: For Majority line: For
12 Feb 2026Cooperation among enforcement authorities regarding unfair trading practices in the agri-food supply chain Passed 555 for, 0 against, 26 abstainedPosition: For Majority line: For
12 Feb 2026Post-election situation in Uganda and threats against opposition leader Bobi Wine Adopted 514 for, 3 against, 56 abstainedPosition: For Majority line: For
12 Feb 2026Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran Adopted 524 for, 3 against, 41 abstainedPosition: For Majority line: For
12 Feb 2026Targeted expulsions of foreign journalists and foreign Christians in Türkiye under national security pretexts Adopted 502 for, 2 against, 59 abstainedPosition: For Majority line: For
12 Feb 2026Developing a new EU anti-poverty strategy Adopted 385 for, 141 against, 53 abstainedPosition: For Majority line: For
12 Feb 2026Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights Adopted 332 for, 209 against, 33 abstainedPosition: For Majority line: For
12 Feb 2026Recommendation to the Council on EU priorities for the 70th session of the UN Commission on the Status of Women Adopted 340 for, 141 against, 68 abstainedPosition: For Majority line: For
12 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire Adopted 363 for, 71 against, 81 abstainedPosition: For Majority line: For
11 Feb 2026Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027 Passed 458 for, 140 against, 44 abstainedPosition: For Majority line: For
11 Feb 2026Amending Regulation (EU) 2024/792 establishing the Ukraine Facility Passed 473 for, 140 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Amending the multiannual financial framework for the years 2021 to 2027 Consent given 490 for, 130 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Mobilisation of the European Globalisation Adjustment Fund: application EGF/2025/006 BE/Audi – Belgium Passed 593 for, 55 against, 9 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified soybean DBN-09004-6 Objection passed 461 for, 169 against, 22 abstainedPosition: Against Majority line: Against
11 Feb 2026Genetically modified maize T25 (ACS-ZMØØ3-2) Objection passed 462 for, 169 against, 22 abstainedPosition: Against Majority line: Against
11 Feb 2026Genetically modified cotton T304-40 Objection passed 428 for, 156 against, 22 abstainedPosition: Against Majority line: Against
11 Feb 2026Genetically modified cotton GHB614 × LLCotton25 Objection passed 463 for, 164 against, 21 abstainedPosition: Against Majority line: Against
11 Feb 2026Interim report in view of the consent procedure on the Agreement establishing an association between the EU and the Principality of Andorra and the Republic of San Marino Interim report adopted 552 for, 24 against, 75 abstainedPosition: For Majority line: For
11 Feb 2026EU strategic defence and security partnerships Adopted 440 for, 119 against, 85 abstainedPosition: For Majority line: For
10 Feb 2026Establishment of a list of safe countries of origin at Union level Passed 408 for, 184 against, 60 abstainedPosition: For Majority line: For
10 Feb 2026Application of the ‘safe third country’ concept Passed 396 for, 226 against, 30 abstainedPosition: For Majority line: For
10 Feb 2026Amending regulations on agricultural products as regards market rules and sectoral support measures in the wine sector and for aromatised wine products Passed 625 for, 15 against, 11 abstainedPosition: For Majority line: For
10 Feb 2026Amending the Measuring Instruments Directive Passed 594 for, 25 against, 23 abstainedPosition: For Majority line: For
10 Feb 2026Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 483 for, 102 against, 67 abstainedPosition: For Majority line: For
10 Feb 2026Framework for achieving climate neutrality Passed 413 for, 226 against, 12 abstainedPosition: Against Majority line: For
10 Feb 2026European Union designs (codification) Passed 613 for, 5 against, 29 abstainedPosition: For Majority line: For
10 Feb 2026European Central Bank – annual report 2025 Adopted 443 for, 71 against, 117 abstainedPosition: For Majority line: For
22 Jan 2026Motion of censure on the Commission Rejected 165 for, 390 against, 10 abstainedPosition: Against Majority line: Against
22 Jan 2026Conviction and imminent sentencing of Jimmy Lai in Hong Kong Adopted 503 for, 9 against, 100 abstainedPosition: For Majority line: For
22 Jan 2026Case of Joseph Figueira Martin in the Central African Republic Adopted 582 for, 0 against, 35 abstainedPosition: For Majority line: For
22 Jan 2026Drones and new systems of warfare – the EU’s need to adapt to be fit for today’s security challenges Adopted 483 for, 68 against, 76 abstainedPosition: For Majority line: For
22 Jan 2026Choice of performance indicators for audit and budgetary control in the context of financing measures to support the implementation of future European competitiveness Adopted 318 for, 247 against, 67 abstainedPosition: For Majority line: For
22 Jan 2026European technological sovereignty and digital infrastructure Adopted 471 for, 68 against, 71 abstainedPosition: For Majority line: For
22 Jan 2026Brutal repression against protesters in Iran Adopted 562 for, 9 against, 57 abstainedPosition: For Majority line: For
22 Jan 2026Attempted takeover of Lithuania’s public broadcaster and the threat to democracy in Lithuania Adopted 385 for, 165 against, 35 abstainedPosition: For Majority line: For
21 Jan 2026Air passenger rights Amendments 1 + 243 (voted as one) adopted 632 for, 15 against, 9 abstainedPosition: For Majority line: For
21 Jan 2026EU-Bosnia and Herzegovina Agreement on operational activities carried out by the European Border and Coast Guard Agency in Bosnia and Herzegovina Consent given 565 for, 83 against, 14 abstainedPosition: For Majority line: For
21 Jan 2026Enhanced cooperation on the establishment of a Loan for Ukraine Consent given 499 for, 135 against, 24 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 19 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Krzysztof HETMAN EPPPoland96 % of 4 016 shared89 %
Jacek PROTAS EPPPoland95 % of 4 257 shared89 %
Marta WCISŁO EPPPoland95 % of 4 353 shared89 %
Bogdan Andrzej ZDROJEWSKI EPPPoland95 % of 4 363 shared89 %
Andrzej BUŁA EPPPoland95 % of 4 003 shared89 %
Kamila GASIUK-PIHOWICZ EPPPoland94 % of 4 317 shared89 %
Dariusz JOŃSKI EPPPoland94 % of 4 334 shared89 %
Bartosz ARŁUKOWICZ EPPPoland94 % of 4 178 shared89 %
Andrzej HALICKI EPPPoland94 % of 4 105 shared89 %
Bartłomiej SIENKIEWICZ EPPPoland94 % of 4 317 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Eugen TOMAC RenewRomania81 % of 3 166 shared82 %
Katri KULMUNI RenewFinland81 % of 3 539 shared82 %
Urmas PAET RenewEstonia81 % of 3 836 shared82 %
Dan BARNA RenewRomania80 % of 3 840 shared82 %
Hilde VAUTMANS RenewBelgium80 % of 4 231 shared82 %
Marie-Pierre VEDRENNE Former memberRenewFrance80 % of 1 976 shared82 %
Bart GROOTHUIS RenewNetherlands79 % of 3 307 shared82 %
Jeannette BALJEU RenewNetherlands79 % of 3 942 shared82 %
Ivars IJABS RenewLatvia79 % of 3 424 shared82 %
Benoit CASSART RenewBelgium79 % of 4 014 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeChair29 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationMember19 Sept 2024now
Delegation for relations with the Korean PeninsulaDKOR DelegationSubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeSubstitute19 Jul 202419 Jan 2025
Committee on Public HealthSANT CommitteeMember23 Jan 202528 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeChair23 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202422 Jul 2024

Show all 10 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
EU Emissions Trading System: heat and fuel benchmark values for 2026–2030RapporteurENVI2 Sept 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsRapporteurSANT16 Apr 2026
24th EU-Republic of South Korea Interparliamentary Meeting\nSeoul 27-29 May 2026Official delegationDKOR16 Apr 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI16 Apr 2026
No dossier namedOfficial delegationSANT24 Mar 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI24 Mar 2026
Laying down the multiannual financial framework for the years 2028 to 2034Opinion rapporteurSANT11 Feb 2026
Guidelines for the 2027 Budget - Section IIIOpinion rapporteurSANT11 Feb 2026
No dossier namedOfficial delegationSANT28 Jan 2026
No dossier namedOfficial delegationSANT9 Oct 2025

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

14 contributions recorded; 2 on behalf of their group; 23 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
14 Sept 2026Emissions trading (joint debate) Speech · 1 minRead
9 Feb 2026World Cancer Day (debate) Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) Speech · 2 minRead
16 Dec 2025Presentation of the EU Cardiovascular Health Plan (debate) Speech · 2 minRead
11 Sept 2025Solidarity with Poland following the deliberate violation of Polish airspace by Russian drones (debate) Speech · 1 minRead
21 May 2025Amending Regulation (EU) 2023/956 as regards simplifying and strengthening the carbon border adjustment mechanism (debate) on behalf of EPPSpeech · 2 minRead
3 Apr 2025European Action Plan on Rare Diseases (debate) Speech · 2 minRead
2 Apr 2025European Steel and Metals Action Plan (debate) Speech · 2 minRead
11 Mar 2025Presentation of the proposal on Critical Medicines Act (CMA) (debate) Speech · 2 minRead
12 Feb 2025Silent crisis: the mental health of Europe’s youth (debate) Speech · 2 minRead
11 Feb 2025The need to address urgent labour shortages and ensure quality jobs in the health care sector (debate) Speech · 2 minRead
23 Oct 2024Tackling the steel crisis: boosting competitive and sustainable European steel and maintaining quality jobs (debate) Speech · 1 minRead
10 Oct 2024World Mental Health Day - need for a comprehensive EU strategy on mental health (debate) on behalf of EPPSpeech · 2 minRead
9 Oct 2024Urgent need to revise the Medical Devices Regulation (debate) Speech · 2 minRead

Questions and motions, 29

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
22 Jun 2026SCoPAFF’s reclassification of plant protection products E-10-2026-002564Written questionwith 1 co-authorNot yet answered
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
25 Mar 2026Ensuring competition and strategic autonomy in the AI gigafactory supply chain E-10-2026-001255Written questionwith 17 co-authors19 Jun 2026
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026
18 Feb 2026Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687Written questionwith 22 co-authorsNot yet answered
18 Feb 2026Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688Written questionwith 21 co-authors21 May 2026
13 Feb 2026Commission proceedings concerning complaint CPLT(2023)02625 on Poland’s restrictions on pharmacy ownership E-10-2026-000645Written questionwith 2 co-authors26 Mar 2026
11 Feb 2026Protecting allergic consumers by harmonising EU ingredient labelling E-10-2026-000591Written questionwith 5 co-authors17 Apr 2026
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026

Show all 29 questions and motions

Amendments tabled in committee, 114

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT35
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT5
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT8
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791073 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791874 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791873 CJ7219
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ538

Show all 114 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Adam JARUBAS”. Member record. memberId 197517. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197517?page=5&scope=final&speeches=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197517?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197517,
  author = {{EU Parl Watch Research}},
  title = {{Adam JARUBAS}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197517?page=5&scope=final&speeches=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197517?page=5&scope=final&speeches=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197517. Official source: https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}